PEN Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Penumbra Medical

Consistent excess liquidity and high margins on thrombectomy systems support the financial foundation of Penumbra, Inc. (PEN). Quarterly EPS variation demonstrates profit dynamics, where the final value of the parameter equals -8.30. Dominance in the emergency stroke care niche guarantees the company flexible pricing power, although global certification challenges and Asian electronics imports create certain operational risks.

Express air freight costs for Penumbra, Inc. (PEN) catheters directly impact net income, as reflected by this indicator. The metric is calculated as the percentage change in EPS over the last three months relative to the same period last year. By analyzing the growth rate of quarterly earnings per share, an investor can track the dynamics of the business's real earnings. A positive trend confirms the effectiveness of operational expense management, while stable growth indicates the resilience of the model amidst expensive logistics.